Coffee Intake Not Linked With Pancreatic Cancer Risk

Share this content:
There may be no association between coffee intake and pancreatic cancer.
There may be no association between coffee intake and pancreatic cancer.

There may be no association between coffee intake and pancreatic cancer, according to a recent study published in the British Journal of Cancer.1

In examining the NIH-AARP Diet and Health Study, Kristin Guertin, PhD, and fellow researchers at the National Cancer Institute looked at 457,366 US adults—“the largest number of pancreatic cancer cases to date”—in order to determine the association between risk and coffee intake, whether caffeinated or decaffeinated. Cox proportional hazards regression was used to estimate hazard ratios.

The researchers found that upon 4,155,256 person-years of follow-up, 1,541 incident first primary pancreatic cancers had occurred. Upon adjusting for smoking history, risk estimates for coffee drinking were not found to be statistically significant.

RELATED: Nab-paclitaxel Plus Gemcitabine Seems Effective After FOLFIRINOX for Pancreatic Cancer

Compared to patients who never drank coffee, hazard ratios for 1.05 for less than one cup of coffee per day, 1.06 for one cup of coffee per day, 1.03 for two to three cups of coffee per day, 1.00 for four to five cups of coffee per day, and 1.24 for at least six cups of coffee per day.

This observation was found to be consistent upon adjusting for other patient characteristics such as sex, smoking status, coffee caffeination and diabetes.

Reference

  1. Guertin KA, Freedman ND, Loftfield E, et al. A prospective study of coffee intake and pancreatic cancer: results from the NIH-AARP Diet and Health Study. [published online ahead of print September 24, 2015]. Br J Cancer. doi: 10.1038/bjc.2015.235.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters